Bank of Nova Scotia’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.09M Buy
60,000
+19,958
+50% +$1.4M 0.01% 671
2025
Q4
$3.69M Buy
40,042
+15,844
+65% +$1.52M 0.01% 692
2025
Q3
$1.8M Buy
+24,198
New +$2.45M ﹤0.01% 723
2025
Q2
Sell
-1,954
Closed -$311K 1060
2025
Q1
$311K Sell
1,954
-623
-24% -$113K ﹤0.01% 873
2024
Q4
$478K Buy
+2,577
New +$500K ﹤0.01% 855

Other funds holding INSP

Bank of Nova Scotia's INSP Position: Q1 2026 in Review

Bank of Nova Scotia increased its Inspire Medical Systems (INSP) stake by 50% in Q1 2026, buying an estimated $1.4M and bringing the position to 60,000 shares worth $3.09M. The position accounts for 0.01% of the portfolio, ranked #671.

Bank of Nova Scotia first reported a position in INSP in Q4 2024 and has held it in 5 quarters since. The position peaked at $3.69M in Q4 2025. 301 funds tracked by Wall St. Rank hold INSP as of Q1 2026.

  • Bank of Nova Scotia held 60,000 shares of Inspire Medical Systems worth $3.09M as of Q1 2026.
  • Bank of Nova Scotia bought 19,958 Inspire Medical Systems shares in Q1 2026, an estimated $1.4M.
  • Inspire Medical Systems made up 0.01% of Bank of Nova Scotia's portfolio in Q1 2026, its #671 holding.
  • Bank of Nova Scotia first reported a position in Inspire Medical Systems in Q4 2024 and has held it in 5 quarters since.
  • Bank of Nova Scotia's Inspire Medical Systems position peaked at $3.69M in Q4 2025.
  • 301 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2026.

Based on Bank of Nova Scotia's 13F filing for Q1 2026, filed 14 May 2026.